Back to the Top
IVIVC article by FDA authors using deconvoluted in vivo absorption approach
introduced by GastroPlus(TM) many years ago.
Pharm Res. 2012 Aug 22. [Epub ahead of print]
Use of In Vitro-In Vivo Correlation to Predict the Pharmacokinetics of Several
Products Containing a BCS Class 1 Drug in Extended Release Matrices.
Mirza T, Bykadi SA, Ellison CD, Yang Y, Davit BM, Khan MA.
Food and Drug Administration Division of Product Quality Research,
(CDER/OPS/OTR/DPQR), White Oak, LS Building 64 10903 New Hampshire Ave, Silver
Spring, Maryland, 20993, USA, Tahseen.mirza.-at-.fda.hhs.gov.
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "New article on IVIVC by FDA" as the subject
Support PharmPK by using the
Copyright 1995-2011 David W. A. Bourne (firstname.lastname@example.org)